Compare Ionis Pharmaceuticals Inc. Common Stock (IONS) vs StandardAero Inc. Common Stock (SARO) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Ionis Pharmaceuticals Inc. Common Stock vs StandardAero Inc. Common Stock — how do they compare? Ionis Pharmaceuticals Inc. Common Stock trades at $43.2 (market cap $7.10B), while StandardAero Inc. Common Stock trades at $19.73 (market cap $6.54B). The key difference: Ionis Pharmaceuticals Inc. Common Stock and StandardAero Inc. Common Stock are close in size by market cap, and StandardAero Inc. Common Stock is more actively traded (2,352,783 versus 2,027,457). Which is the better fit depends on your goals — on Pluang, investors hold Ionis Pharmaceuticals Inc. Common Stock for 0 Days and StandardAero Inc. Common Stock for 0 Days on average.
| IONS | SARO | |
|---|---|---|
Market Cap | $7.10B | $6.54B |
Volume | 2,027,457 | 2,352,783 |
Sector | Health | Industrials |
52-Week High | $86.50 | $33.12 |
52-Week Low | $42.38 | $19.76 |
Typical Hold Time | 0 Days | 0 Days |
Enterprise Value | $6.66B | $8.92B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About Ionis Pharmaceuticals Inc. Common Stock
Ionis Pharmaceuticals Inc. is a biopharmaceutical company that develops RNA-targeted medicines using its antisense technology, with marketed treatments in neurology and cardiometabolic disease.
Read more on IONS →About StandardAero Inc. Common Stock
StandardAero, Inc. is an independent provider of aircraft engine maintenance, repair, and overhaul services, supporting commercial, military, and business aviation customers across more than 40 engine platforms.
Read more on SARO →
